Form 4: GoodRx CAO Romin Nabiey Reports Stock Transactions

GoodRx Chief Accounting Officer Romin Nabiey reported the acquisition of shares from restricted stock units and subsequent sale for tax purposes.

Summary

• Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc. (GDRX), reported transactions involving Class A Common Stock.
• On November 8, 2025, Nabiey acquired 12,662 shares of Class A Common Stock through the vesting of restricted stock units (RSUs).
• Following the acquisition, Nabiey's direct beneficial ownership of Class A Common Stock was 157,938 shares.
• On the same date, Nabiey disposed of 4,531 shares of Class A Common Stock at a price of $3.11 per share.
• After these transactions, Nabiey's direct beneficial ownership of Class A Common Stock stands at 153,407 shares.
• Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
• The RSUs vest as to 6.25% of the underlying shares on August 8, 2023, with the remaining 93.75% vesting in approximately equal quarterly installments over 15 quarters thereafter.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects the routine vesting of executive equity compensation, indicating continued alignment of management with shareholder interests, despite a partial sale for tax purposes.

Positives

• The vesting of 12,662 restricted stock units indicates continued equity compensation for the Chief Accounting Officer, aligning management interests with shareholders.
• The acquisition of shares through RSU vesting demonstrates the company's commitment to its long-term incentive plans for executives.

Negatives

• The disposition of 4,531 shares, although likely for tax withholding purposes, reduces the direct beneficial ownership of the Chief Accounting Officer.

Future Outlook

N/A

Industry Context

N/A

Stakeholder Impact

• Shareholders: The transaction represents a routine insider activity, with the Chief Accounting Officer acquiring shares through vesting and selling a portion for tax purposes. This generally has a neutral to slightly positive impact as it shows continued executive equity ownership and alignment.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent sale for tax purposes. Such transactions are common and do not typically indicate a change in the company's fundamental outlook or operational performance. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

GoodRx, GDRX, Romin Nabiey, Form 4, Insider Transaction, Restricted Stock Units, Equity Compensation, Chief Accounting Officer, Stock Sale, Tax Withholding